首页 › 基金 › ARCH Venture Management, LLC › PBLS
ARCH Venture Management, LLC 对 PBLS 的持仓历史
PARABILIS MEDICINES INC · 医疗保健
ARCH Venture Management, LLC 在 Q3 2026 的 13F 申报中披露持有 PBLS(PARABILIS MEDICINES INC)6,412,780 股,市值约 US$207.1M,约占其申报组合的 12.83%,在其申报持仓中市值排名第 2 位。 ARCH Venture Management, LLC 最近 2 个申报季度中有 2 个季度披露了 PBLS 持仓,最早可追溯至 Q2 2026。
最后更新: 2026-11-17 · 来源: SEC EDGAR Form 13F-HR
ARCH Venture Management, LLC 对 PBLS 的持仓演变
ARCH Venture Management, LLC 于 Q2 2026 首次披露 PBLS 持仓:6,412,780 股(约 US$175.5M)。 该持仓在 Q3 2026 达到峰值 6,412,780 股,市值约 US$207.1M。 在 2 次申报中,ARCH Venture Management, LLC 的持股数量始终未变。 最近一期申报(Q3 2026)显示持股 6,412,780 股、市值约 US$207.1M。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q2 2026 | 6.41M | $175.52M | 新进 |
| Q3 2026 | 6.41M | $207.07M | 持有 |
折线上的点按变动类型着色;缺失季度表示该季未申报持仓。
关于 PBLS 与 13F 数据
PBLS(PARABILIS MEDICINES INC)属于医疗保健行业。我们追踪的基金中还有 129 只申报持有 PBLS,申报仓位最大的包括:RA CAPITAL MANAGEMENT, L.P. (US$942.2M), venBio Partners LLC (US$170.1M), Alphabet Inc. (US$158.9M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
其它持有 PBLS 的基金
- RA CAPITAL MANAGEMENT, L.P. 29.18M 股 · $942.16M · Q3 2026
- venBio Partners LLC 5.27M 股 · $170.06M · Q3 2026
- Alphabet Inc. 4.92M 股 · $158.85M · Q3 2026
- Nextech Invest Ltd. 4.66M 股 · $150.57M · Q3 2026
- Cormorant Asset Management, LP 4.62M 股 · $149.04M · Q3 2026
- REGENERON PHARMACEUTICALS, INC. 4.17M 股 · $134.54M · Q3 2026
- Siren, L.L.C. 2.99M 股 · $96.62M · Q3 2026
- FARALLON CAPITAL MANAGEMENT, L.L.C. 2.37M 股 · $76.47M · Q3 2026
- Frazier Life Sciences Management, L.P. 2.33M 股 · $75.26M · Q3 2026
- 法拉龙资本管理 2.37M 股 · $64.82M · Q2 2026
- DEERFIELD MANAGEMENT COMPANY, L.P. 1.88M 股 · $60.73M · Q3 2026
- Soleus Capital Management, L.P. 1.68M 股 · $54.39M · Q3 2026
更多关于 ARCH Venture Management, LLC
常见问题
How long has ARCH Venture Management, LLC held PBLS?
ARCH Venture Management, LLC has disclosed PBLS holdings in 2 of the last 2 reported quarters, going back to Q2 2026.
What is ARCH Venture Management, LLC's current position in PBLS?
As of Q3 2026, ARCH Venture Management, LLC holds 6.41M shares of PBLS (PARABILIS MEDICINES INC), valued at $207.07M, representing 12.83% of its reported portfolio and ranking #2.
Has ARCH Venture Management, LLC been buying or selling PBLS?
In the latest 13F filing (Q3 2026), ARCH Venture Management, LLC held unchanged its position in PBLS. The position peaked in Q3 2026 at 6.41M shares.
Which other funds hold PBLS?
Other major institutional holders of PBLS include RA CAPITAL MANAGEMENT, L.P., venBio Partners LLC, Alphabet Inc., among 129 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.